SERES THERAPEUTICS INC (MCRB:NASDAQ)

$4.83 0.05 (1.046%)

watchlist-icon
search-icon
Profile Icon

Most Recent Average Sentiment Analysis Score (0 to 100): 77

negative-sentiment
Negative [0, 35)
neutral-sentiment
Neutral [35, 65]
positive-sentiment
Positive (65, 100]
Visualize Sentiment Trendline

Analysed SERES THERAPEUTICS INC (MCRB:NASDAQ) News Sources

Seres Therapeutics to Present at CARB-X Investor Day

09-04-2026

yahoo.com

Seres Therapeutics Showcases SER-155 Data and Live Biotherapeutic Insights at ESCMID Global 2026

20-04-2026

yahoo.com

Seres Therapeutics Presents Preclinical Data at Digestive Disease Week (DDW) 2026 Supporting SER-603, a Next-Generation Cultivated Live Biotherapeutic Candidate, for Inflammatory Bowel Disease

04-05-2026

yahoo.com

Seres Therapeutics Reports First Quarter 2026 Financial Results and Provides Business Updates

05-05-2026

yahoo.com

Seres Therapeutics to Participate in H.C. Wainwright 4th Annual BioConnect Investor Conference

12-05-2026

yahoo.com

Seres Therapeutics Announces Two Transactions to Strengthen Balance Sheet, Reduce On-Going Lease Costs and Extend Projected Operating Cash Runway Well Into the First Quarter of 2027

05-06-2026

yahoo.com

We're A Little Worried About Seres Therapeutics' (NASDAQ:MCRB) Cash Burn Rate

13-06-2026

yahoo.com

Seres Therapeutics to Host Webcast on July 8, 2026, to Discuss Results of Investigator-Sponsored Trial of Seres’ SER-155 in Immune Checkpoint Inhibitor-Related Enterocolitis

25-06-2026

yahoo.com

Seres Therapeutics Announces Early Clinical Data Showing Potential for SER-155 in Immune Checkpoint Inhibitor-Related Enterocolitis (irEC), a Frequent Adverse Reaction That Forces Many Patients to Halt Cancer Treatment

08-07-2026

yahoo.com

Seres Therapeutics’ SER-155 Posts 80% Response in Cancer Immunotherapy GI Toxicity Study

10-07-2026

marketbeat.com

SERES THERAPEUTICS INC (MCRB:NASDAQ) Sentiment Trend

0 25 50 75 100 85 80 81 89 78 80 35 85 66 86 09-04-2026 20-04-2026 04-05-2026 05-05-2026 12-05-2026 05-06-2026 13-06-2026 25-06-2026 08-07-2026 10-07-2026 #1 #2 #3 #4 #5 #6 #7 #8 #9 #10 Negative < 35 Neutral 35–65 Positive > 65 View FAQ

SERES THERAPEUTICS INC (MCRB:NASDAQ) FAQs

toggle

What is the current price of SERES THERAPEUTICS INC (MCRB:NASDAQ)?

The current price of SERES THERAPEUTICS INC (MCRB:NASDAQ) is $4.83.


toggle

SERES THERAPEUTICS INC (MCRB:NASDAQ) absolute price change since previous trading day?

The absolute price change of SERES THERAPEUTICS INC (MCRB:NASDAQ) since the previous trading day is $0.05.


toggle

SERES THERAPEUTICS INC (MCRB:NASDAQ) percentage price change since previous trading day?

The percentage price change of SERES THERAPEUTICS INC (MCRB:NASDAQ) since the previous trading day is 1.046%.


toggle

What is the most recent average sentiment score for SERES THERAPEUTICS INC (MCRB:NASDAQ)?

The most recent average sentiment score for SERES THERAPEUTICS INC (MCRB:NASDAQ) is 77 out of 100.


toggle

What is the most recent average sentiment for SERES THERAPEUTICS INC (MCRB:NASDAQ)?

The most recent sentiment for SERES THERAPEUTICS INC (MCRB:NASDAQ) is .


SEC-8K** Filing Available For SERES THERAPEUTICS INC (MCRB:NASDAQ)

** material developments that could impact a company's financial condition or stock price.

Author: MattELab

X Icon

GitHub Icon

MattELab is the founder and lead developer of SentientMerchant. With a Computer Science and Quantitative Finance background from a T10 university, he brings over 6 years of expertise in NLP, programmatic SEO, and full-stack development to build highly scalable AI and FinTech solutions.